EPHESUS Trial
- 6,200 participants
- 5 sites in New Zealand
Eplerenone In Heart Failure Post Acute Myocardial Infarction. Double-blind, randomised, placebo-controlled trial evaluating the safety and efficacy of eplerenone in patients with heart failure following acute myocardial infarction.